» Articles » PMID: 1825438

Platelet Activating Factor (PAF) Antagonists: Development of a Highly Potent PAF Antagonist, TCV-309

Overview
Date 1991 Jan 1
PMID 1825438
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Canale P, Squadrito F, Altavilla D, Ioculano M, Zingarelli B, Campo G Agents Actions. 1994; 42(3-4):128-34.

PMID: 7879698 DOI: 10.1007/BF01983478.


Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.

Konturek S, Dembinski A, Konturek P, Warzecha Z, Jaworek J, Gustaw P Gut. 1992; 33(9):1268-74.

PMID: 1385272 PMC: 1379500. DOI: 10.1136/gut.33.9.1268.